Discover high-impact technologies and emerging solutions in Québec’s RNA ecosystem.
Every one-pager in the portfolio includes:
- Full proposition and essential statistics
- Raised funds
- Milestones
- Business model and opportunities
- Market analyses
- Team members
Full RNA portfolio
PDF – 12 pages
COULD THIS BE A GOOD TIME TO INVEST ?
Portfolio content
High-impact proposals
- Espoir Biosciences : Reactivating the Brain’s Repair Mechanisms to Reverse Neurodegeneration
- Nanofacile™ Symphony Kit : Accelerating RNA therapy discovery & development
- Cell-Immune Pharma : Engineering Human-Derived T-Cell Solutions to Supercharge Vaccines & Immunotherapies
Emerging solutions
- RNABioPrecision: Reprogramming disease networks with synthetic RNA molecules inspired by natural microRNAs
- Chemically Modified CRISPR crRNA for Advanced Gene Editing Applications
- RNOVA Tx: Innovative antisense strategies targeting SRSF3 to reprogram immune response in neurodegenerative disorders
- Prevention of Cancer∕Metastasis Through an Antibody-Oligo-Conjugate (AOC) Platform
- Layer-by-Layer Lipid Nanoparticles for Enhanced Gene and Drug Delivery
- DNA-Encoded Functionalized Aptamers
- Smart Anti-Infective Antisense Strategy and Molecules
- Novel Treatment for Microvessel Rarefaction
High-impact Proposals
Espoir Biosciences
Reactivating the Brain’s Repair Mechanisms to Reverse Neurodegeneration
Cell-Immune Pharma (CIP)
Engineering Human-Derived T-Cell Solutions to Supercharge Vaccines & Immunotherapies
Emerging solutions
RNABioPrecision: Reprogramming disease networks with synthetic RNA molecules inspired by natural microRNAs
IRIC-UdeM
Chemically Modified CRISPR crRNA for Advanced Gene Editing Applications
McGill
RNOVA Tx: Innovative antisense strategies targeting SRSF3 to reprogram immune response in neurodegenerative disorders
Université de Laval
Prevention of Cancer∕Metastasis Through an Antibody-Oligo-Conjugate (AOC) Platform
IRCM
Layer-by-Layer Lipid Nanoparticles for Enhanced Gene and Drug Delivery
CHU Sainte-Justine-UdeM
DNA-Encoded Functionalized Aptamers
McGill
Smart Anti-Infective Antisense Strategy and Molecules
McGill
Novel Treatment for Microvessel Rarefaction
CrCHUM